Yin Xianyong, Gao Jiajia, Liu Zihao, Han Min, Ji Xiaoshuai, Wang Zhihai, Li Yuming, He Dong, Zhang Fenglin, Liu Qian, Xin Tao
Department of Neurosurgery, Shandong Medicine and Health Key Laboratory of Neurosurgery, The First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Jinan, China.
Department of Neurosurgery, Shandong Provincial Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Front Oncol. 2022 Jul 14;12:941327. doi: 10.3389/fonc.2022.941327. eCollection 2022.
Glioma, one of the most common malignant tumors in the nervous system, is characterized by limited treatment, high mortality and poor prognosis. Numerous studies have shown that lncRNAs play an important role in the onset and progression of glioma by acting on various classical signaling pathways of tumors through signaling, trapping, guiding, scaffolding and other functions. LncRNAs contribute to the malignant progression of glioma proliferation, apoptosis, epithelial-mesenchymal transformation, chemotherapy resistance, ferroptosis and other biological traits. In this paper, relevant lncRNA signaling pathways involved in glioma progression were systematically evaluated, with emphasis placed on the specific molecular mechanism of lncRNAs in the process of ferroptosis, in order to provide a theoretical basis for the application of lncRNAs in the anticancer treatment of glioma.
胶质瘤是神经系统最常见的恶性肿瘤之一,其特点是治疗手段有限、死亡率高且预后不良。大量研究表明,长链非编码RNA(lncRNAs)通过信号传导、捕获、引导、支架等功能作用于肿瘤的各种经典信号通路,在胶质瘤的发生和发展中发挥重要作用。lncRNAs有助于胶质瘤的恶性进展,包括增殖、凋亡、上皮-间质转化、化疗耐药、铁死亡等生物学特性。本文系统评估了参与胶质瘤进展的相关lncRNA信号通路,重点关注lncRNAs在铁死亡过程中的具体分子机制,以期为lncRNAs在胶质瘤抗癌治疗中的应用提供理论依据。